Connection

Brent Egan to Adult

This is a "connection" page, showing publications Brent Egan has written about Adult.
Connection Strength

2.126
  1. Association of Baseline Adherence to Antihypertensive Medications With Adherence After Shelter-in-Place Guidance for COVID-19 Among US Adults. JAMA Netw Open. 2022 12 01; 5(12):e2247787.
    View in: PubMed
    Score: 0.059
  2. Hypertension Control Among US Adults, 2009 to 2012 Through 2017 to 2020, and the Impact of COVID-19. Hypertension. 2022 09; 79(9):1981-1983.
    View in: PubMed
    Score: 0.058
  3. Hypertension Control in the United States 2009 to 2018: Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups. Hypertension. 2021 09; 78(3):578-587.
    View in: PubMed
    Score: 0.053
  4. Sociodemographic Determinants of Life's Simple 7: Implications for Achieving Cardiovascular Health and Health Equity Goals. Ethn Dis. 2020; 30(4):637-650.
    View in: PubMed
    Score: 0.051
  5. Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial. Addiction. 2020 07; 115(7):1358-1367.
    View in: PubMed
    Score: 0.048
  6. Habitual protein intake, protein distribution patterns and dietary sources in Irish adults with stratification by sex and age. J Hum Nutr Diet. 2020 08; 33(4):465-476.
    View in: PubMed
    Score: 0.048
  7. The prevalence of concurrently raised blood glucose and blood pressure in India. J Hypertens. 2019 09; 37(9):1788-1789.
    View in: PubMed
    Score: 0.047
  8. Defining Hypertension by Blood Pressure 130/80 mm Hg Leads to an Impressive Burden of Hypertension in Young and Middle-Aged Black Adults: Follow-Up in the CARDIA Study. J Am Heart Assoc. 2018 07 14; 7(14).
    View in: PubMed
    Score: 0.043
  9. Differences in primary cardiovascular disease prevention between the 2013 and 2016 cholesterol guidelines and impact of the 2017 hypertension guideline in the United States. J Clin Hypertens (Greenwich). 2018 06; 20(6):991-1000.
    View in: PubMed
    Score: 0.043
  10. Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results. J Clin Hypertens (Greenwich). 2018 01; 20(1):79-87.
    View in: PubMed
    Score: 0.042
  11. Cholesterol Control Among Uninsured Adults Did Not Improve From 2001-2004 to 2009-2012 as Disparities With Both Publicly and Privately Insured Adults Doubled. J Am Heart Assoc. 2017 Nov 02; 6(11).
    View in: PubMed
    Score: 0.041
  12. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012. Hypertension. 2017 08; 70(2):275-284.
    View in: PubMed
    Score: 0.040
  13. Opportunities for improving cardiovascular health outcomes in adults younger than 65?years with guideline-recommended statin therapy. J Clin Hypertens (Greenwich). 2017 Sep; 19(9):850-860.
    View in: PubMed
    Score: 0.040
  14. Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2017 Mar; 19(3):241-249.
    View in: PubMed
    Score: 0.039
  15. 2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals. J Am Heart Assoc. 2016 08 19; 5(8).
    View in: PubMed
    Score: 0.038
  16. Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2016 08; 18(8):817-24.
    View in: PubMed
    Score: 0.037
  17. Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network. Ther Adv Cardiovasc Dis. 2016 Apr; 10(2):56-66.
    View in: PubMed
    Score: 0.036
  18. Impact of Implementing the 2013 ACC/AHA Cholesterol Guidelines on Vascular Events in a Statewide Community-Based Practice Registry. J Clin Hypertens (Greenwich). 2016 07; 18(7):663-71.
    View in: PubMed
    Score: 0.036
  19. Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences. Ethn Dis. 2015 Nov 05; 25(4):511-4.
    View in: PubMed
    Score: 0.036
  20. Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks. J Clin Hypertens (Greenwich). 2015 Apr; 17(4):252-9.
    View in: PubMed
    Score: 0.034
  21. The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010. Hypertension. 2014 Nov; 64(5):997-1004.
    View in: PubMed
    Score: 0.033
  22. Diabetes and age-related demographic differences in risk factor control. J Am Soc Hypertens. 2014 Jun; 8(6):394-404.
    View in: PubMed
    Score: 0.033
  23. Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010. Circulation. 2014 May 20; 129(20):2052-61.
    View in: PubMed
    Score: 0.032
  24. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010. Circulation. 2013 Jul 02; 128(1):29-41.
    View in: PubMed
    Score: 0.031
  25. Associations among environmental supports, physical activity, and blood pressure in African-American adults in the PATH trial. Soc Sci Med. 2013 Jun; 87:108-15.
    View in: PubMed
    Score: 0.030
  26. Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals. J Clin Hypertens (Greenwich). 2013 Mar; 15(3):154-61.
    View in: PubMed
    Score: 0.030
  27. Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008. J Clin Hypertens (Greenwich). 2012 Nov; 14(11):751-9.
    View in: PubMed
    Score: 0.029
  28. Demographic differences in the treatment and control of glucose in type 2 diabetic patients: implications for health care practice. Ethn Dis. 2012; 22(1):29-37.
    View in: PubMed
    Score: 0.028
  29. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011 Oct; 58(4):579-87.
    View in: PubMed
    Score: 0.027
  30. Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative. J Clin Hypertens (Greenwich). 2011 Aug; 13(8):543-50.
    View in: PubMed
    Score: 0.027
  31. Prehypertension: an opportunity for a new public health paradigm. Cardiol Clin. 2010 Nov; 28(4):561-9.
    View in: PubMed
    Score: 0.025
  32. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010 May 26; 303(20):2043-50.
    View in: PubMed
    Score: 0.025
  33. Antihypertensive medication prescribing patterns in a university teaching hospital. J Clin Hypertens (Greenwich). 2010 Apr; 12(4):246-52.
    View in: PubMed
    Score: 0.024
  34. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010 Apr; 24(4):237-46.
    View in: PubMed
    Score: 0.023
  35. Pleiotropic benefits of moderate salt reduction. Hypertension. 2009 Sep; 54(3):447-8.
    View in: PubMed
    Score: 0.023
  36. Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans. J Hum Hypertens. 2009 Dec; 23(12):826-35.
    View in: PubMed
    Score: 0.023
  37. Concordance between self-reported heights and weights and current and ideal body images in young adult African American men and women. Ethn Dis. 2007; 17(4):617-23.
    View in: PubMed
    Score: 0.020
  38. Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J Clin Hypertens (Greenwich). 2005 Dec; 7(12):705-11; quiz 712-3.
    View in: PubMed
    Score: 0.018
  39. Prevalence, treatment, and control of chest pain syndromes and associated risk factors in hypertensive patients. Am J Hypertens. 2005 Aug; 18(8):1026-32.
    View in: PubMed
    Score: 0.018
  40. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005 Jul-Aug; 3(4):294-9.
    View in: PubMed
    Score: 0.018
  41. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens. 2005 Jan; 18(1):3-12.
    View in: PubMed
    Score: 0.017
  42. Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients. Ethn Dis. 2005; 15(1):25-32.
    View in: PubMed
    Score: 0.017
  43. Prehypertension and mortality in a nationally representative cohort. Am J Cardiol. 2004 Dec 15; 94(12):1496-500.
    View in: PubMed
    Score: 0.017
  44. Lipids enhance alpha1-adrenoceptor pressor sensitivity in patients with chronic kidney disease. Am J Kidney Dis. 2004 Sep; 44(3):446-54.
    View in: PubMed
    Score: 0.017
  45. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens. 2004 Jun; 17(6):477-82.
    View in: PubMed
    Score: 0.016
  46. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25.
    View in: PubMed
    Score: 0.016
  47. An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):26-31; quiz 32-3.
    View in: PubMed
    Score: 0.016
  48. Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report? J Investig Med. 2003 Nov; 51(6):373-85.
    View in: PubMed
    Score: 0.016
  49. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension. 2003 Mar; 41(3):422-30.
    View in: PubMed
    Score: 0.015
  50. Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects. Am J Hypertens. 2003 Jan; 16(1):67-71.
    View in: PubMed
    Score: 0.015
  51. Blood Pressure Control Among Non-Hispanic Black Adults Is Lower Than Non-Hispanic White Adults Despite Similar Treatment With Antihypertensive Medication: NHANES 2013-2018. Am J Hypertens. 2022 Jun 16; 35(6):514-525.
    View in: PubMed
    Score: 0.014
  52. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens. 2002 Jun; 20(6):1215-21.
    View in: PubMed
    Score: 0.014
  53. Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control Hypertension. Am J Hypertens. 2022 03 08; 35(3):232-243.
    View in: PubMed
    Score: 0.014
  54. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. Hypertension. 2001 Oct; 38(4):858-63.
    View in: PubMed
    Score: 0.014
  55. The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents. Am J Hypertens. 2001 Oct; 14(10):1032-7.
    View in: PubMed
    Score: 0.014
  56. Hemodynamic effects of lipids in humans. Am J Physiol Regul Integr Comp Physiol. 2001 Jun; 280(6):R1674-9.
    View in: PubMed
    Score: 0.013
  57. The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control. J S C Med Assoc. 2001 Feb; 97(2):57-62.
    View in: PubMed
    Score: 0.013
  58. Acute physical and mental stress resulted in an increase in fatty acids, norepinephrine, and hemodynamic changes in normal individuals: A possible pathophysiological mechanism for hypertension-Pilot study. J Clin Hypertens (Greenwich). 2021 04; 23(4):888-894.
    View in: PubMed
    Score: 0.013
  59. Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis. Ir J Med Sci. 2020 Aug; 189(3):1023-1026.
    View in: PubMed
    Score: 0.012
  60. The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States. Am J Med Sci. 1999 Dec; 318(6):365-8.
    View in: PubMed
    Score: 0.012
  61. Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity. Hypertension. 1998 Oct; 32(4):693-8.
    View in: PubMed
    Score: 0.011
  62. Fatty acids augment endothelium-dependent dilation in hand veins by a cyclooxygenase-dependent mechanism. Hypertension. 1997 Dec; 30(6):1634-9.
    View in: PubMed
    Score: 0.010
  63. Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins. Hypertension. 1997 Nov; 30(5):1150-5.
    View in: PubMed
    Score: 0.010
  64. Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors. Am J Physiol. 1996 Jun; 270(6 Pt 2):R1340-6.
    View in: PubMed
    Score: 0.009
  65. Abnormalities of Anthropometric, Hemodynamic, and Autonomic Variables in Offspring of Hypertensive Parents. J Clin Hypertens (Greenwich). 2016 09; 18(9):942-8.
    View in: PubMed
    Score: 0.009
  66. Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension. 1996 Mar; 27(3 Pt 2):723-8.
    View in: PubMed
    Score: 0.009
  67. Orthopaedic complications following cardiac transplantation. Ir Med J. 1996 Jan-Feb; 89(1):26-7.
    View in: PubMed
    Score: 0.009
  68. Social and Medical Determinants of Cardiometabolic Health: The Big Picture. Ethn Dis. 2015 Nov 05; 25(4):521-4.
    View in: PubMed
    Score: 0.009
  69. The Results of the "Positive Action for Today's Health" (PATH) Trial for Increasing Walking and Physical Activity in Underserved African-American Communities. Ann Behav Med. 2015 Jun; 49(3):398-410.
    View in: PubMed
    Score: 0.009
  70. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 1995 Apr; 25(4 Pt 2):774-8.
    View in: PubMed
    Score: 0.009
  71. Chaos to complexity: leveling the playing field for measuring value in primary care. J Eval Clin Pract. 2017 Apr; 23(2):430-438.
    View in: PubMed
    Score: 0.009
  72. Additive effects of obesity and hypertension to limit venous volume. Am J Physiol. 1995 Feb; 268(2 Pt 2):R562-8.
    View in: PubMed
    Score: 0.009
  73. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens. 1994 Oct; 7(10 Pt 1):886-93.
    View in: PubMed
    Score: 0.008
  74. Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives. J Hypertens. 1994 Sep; 12(9):1061-7.
    View in: PubMed
    Score: 0.008
  75. Elevated blood pressures in obese young men with mild hypertension are sustained during the day and night. Am J Hypertens. 1994 Jul; 7(7 Pt 1):609-14.
    View in: PubMed
    Score: 0.008
  76. Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2014 Jul; 261(7):1405-12.
    View in: PubMed
    Score: 0.008
  77. In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertension. J Hypertens. 2014 Feb; 32(2):251-9.
    View in: PubMed
    Score: 0.008
  78. Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects. Hypertension. 1994 Jan; 23(1 Suppl):I1-7.
    View in: PubMed
    Score: 0.008
  79. The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion. Clinics (Sao Paulo). 2013 Dec; 68(12):1495-501.
    View in: PubMed
    Score: 0.008
  80. Epithelial sodium channel inhibition by amiloride on blood pressure and cardiovascular disease risk in young prehypertensives. J Clin Hypertens (Greenwich). 2014 Jan; 16(1):47-53.
    View in: PubMed
    Score: 0.008
  81. Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993 Oct; 22(4):584-90.
    View in: PubMed
    Score: 0.008
  82. Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension. Am J Cardiol. 1993 Jul 01; 72(1):53-7.
    View in: PubMed
    Score: 0.008
  83. Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol. 1992 Nov 15; 70(15):1347-52.
    View in: PubMed
    Score: 0.007
  84. Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2013 Feb; 260(2):590-6.
    View in: PubMed
    Score: 0.007
  85. Influences on infant feeding decisions of first-time mothers in five European countries. Eur J Clin Nutr. 2012 Aug; 66(8):914-9.
    View in: PubMed
    Score: 0.007
  86. Cardiovascular risk factors, clustering and complications in overweight young men. Med Sect Proc. 1992; 107-15.
    View in: PubMed
    Score: 0.007
  87. NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men. Am J Hypertens. 1991 Dec; 4(12 Pt 1):924-31.
    View in: PubMed
    Score: 0.007
  88. Popliteo-pedal bypass surgery for critical limb ischemia. Ir J Med Sci. 2011 Dec; 180(4):829-35.
    View in: PubMed
    Score: 0.007
  89. Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status. Am J Hypertens. 1991 May; 4(5 Pt 1):416-21.
    View in: PubMed
    Score: 0.007
  90. Comparative effects of overweight on cardiovascular risk in younger versus older men. Am J Cardiol. 1991 Feb 01; 67(4):248-52.
    View in: PubMed
    Score: 0.006
  91. Cardiovascular disease risk factor clustering among African American adults. Ethn Dis. 2011; 21(2):129-34.
    View in: PubMed
    Score: 0.006
  92. Potential deleterious impact of dietary salt restriction on cardiovascular risk factors. Klin Wochenschr. 1991; 69 Suppl 25:45-50.
    View in: PubMed
    Score: 0.006
  93. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. Cardiovasc Ther. 2010 Dec; 28(6):344-9.
    View in: PubMed
    Score: 0.006
  94. Attitudes and practices of resident physicians regarding hypertension in the inpatient setting. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):698-705.
    View in: PubMed
    Score: 0.006
  95. An overview of the "Positive Action for Today's Health" (PATH) trial for increasing walking in low income, ethnic minority communities. Contemp Clin Trials. 2010 Nov; 31(6):624-33.
    View in: PubMed
    Score: 0.006
  96. Importance of overweight in studies of left ventricular hypertrophy and diastolic function in mild systemic hypertension. Am J Cardiol. 1989 Oct 01; 64(12):752-5.
    View in: PubMed
    Score: 0.006
  97. Erythrocyte water, Na+-K+ cotransport, and forearm vascular function in humans. Hypertension. 1988 Aug; 12(2):199-203.
    View in: PubMed
    Score: 0.005
  98. Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension. Am J Hypertens. 1988 Jul; 1(3 Pt 3):324S-330S.
    View in: PubMed
    Score: 0.005
  99. An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J Clin Hypertens (Greenwich). 2008 Jun; 10(6):436-42.
    View in: PubMed
    Score: 0.005
  100. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99.
    View in: PubMed
    Score: 0.005
  101. Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). Ann Fam Med. 2008 Mar-Apr; 6(2):100-6.
    View in: PubMed
    Score: 0.005
  102. Vascular structure enhances regional resistance responses in mild essential hypertension. J Hypertens. 1988 Jan; 6(1):41-8.
    View in: PubMed
    Score: 0.005
  103. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987 Sep; 80(3):812-7.
    View in: PubMed
    Score: 0.005
  104. Age and race impact the association between BMI and CVD mortality in women. Public Health Rep. 2007 Jul-Aug; 122(4):507-12.
    View in: PubMed
    Score: 0.005
  105. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med. 2007 Mar 12; 167(5):502-6.
    View in: PubMed
    Score: 0.005
  106. The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension. J Clin Hypertens (Greenwich). 2006 Apr; 8(4):257-60.
    View in: PubMed
    Score: 0.005
  107. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006 Apr 20; 354(16):1685-97.
    View in: PubMed
    Score: 0.005
  108. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place. 2007 Mar; 13(1):179-87.
    View in: PubMed
    Score: 0.005
  109. Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther. 1985 Nov; 38(5):519-24.
    View in: PubMed
    Score: 0.005
  110. Arterial compression of the retro-olivary sulcus of the medulla in essential hypertension: a multivariate analysis. J Hypertens. 2005 Nov; 23(11):2027-31.
    View in: PubMed
    Score: 0.005
  111. Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care. 2005 Jun; 28(6):1487-9.
    View in: PubMed
    Score: 0.004
  112. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci. 2005 Jun; 329(6):276-91.
    View in: PubMed
    Score: 0.004
  113. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Am J Med Sci. 2005 Jun; 329(6):292-305.
    View in: PubMed
    Score: 0.004
  114. Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive. Clin Exp Hypertens A. 1985; 7(2-3):243-55.
    View in: PubMed
    Score: 0.004
  115. Role of cardiopulmonary mechanoreceptors in ADH release in normal humans. Hypertension. 1984 Nov-Dec; 6(6 Pt 1):832-6.
    View in: PubMed
    Score: 0.004
  116. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich). 2004 Oct; 6(10):562-8.
    View in: PubMed
    Score: 0.004
  117. Trial of preventing hypertension: design and 2-year progress report. Hypertension. 2004 Aug; 44(2):146-51.
    View in: PubMed
    Score: 0.004
  118. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension. 2004 Feb; 43(2):358-63.
    View in: PubMed
    Score: 0.004
  119. Role of cardiovascular receptors on the neural regulation of renin release in normal men. Hypertension. 1983 Sep-Oct; 5(5):779-86.
    View in: PubMed
    Score: 0.004
  120. Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens. 2003 May; 16(5 Pt 1):331-6.
    View in: PubMed
    Score: 0.004
  121. Associations between birth weight and antihypertensive medication in black and white medicaid recipients. Hypertension. 2002 Jan; 39(1):179-83.
    View in: PubMed
    Score: 0.003
  122. Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens (Greenwich). 2001 Jan-Feb; 3(1):29-31.
    View in: PubMed
    Score: 0.003
  123. Vascular compression of the rostral ventrolateral medulla in sympathetic mediated essential hypertension. Hypertension. 2000 Jul; 36(1):78-82.
    View in: PubMed
    Score: 0.003
  124. Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. Arch Intern Med. 2000 May 22; 160(10):1472-6.
    View in: PubMed
    Score: 0.003
  125. A preliminary report of mortality patterns among foundry workers. J Environ Pathol Toxicol. 1979 May-Jun; 2(5):259-72.
    View in: PubMed
    Score: 0.003
  126. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun; 60(5-6):401-5.
    View in: PubMed
    Score: 0.003
  127. Aldosterone in obesity. Endocr Res. 1998 Aug-Nov; 24(3-4):789-96.
    View in: PubMed
    Score: 0.003
  128. Commun-I-Care: experience in the first four years. J S C Med Assoc. 1998 Jul; 94(7):318-22.
    View in: PubMed
    Score: 0.003
  129. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997 Apr; 313(4):195-209.
    View in: PubMed
    Score: 0.002
  130. Differences in macronutrient selections in users and nonusers of an oral contraceptive. Am J Clin Nutr. 1997 Feb; 65(2):419-24.
    View in: PubMed
    Score: 0.002
  131. Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. Am J Hypertens. 1997 Jan; 10(1):68-76.
    View in: PubMed
    Score: 0.002
  132. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension. 1996 Jul; 28(1):120-6.
    View in: PubMed
    Score: 0.002
  133. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 1995 Jul; 26(1):186-92.
    View in: PubMed
    Score: 0.002
  134. Effect of circulating epinephrine on platelet function and hematocrit. Hypertension. 1995 May; 25(5):1096-105.
    View in: PubMed
    Score: 0.002
  135. Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans. Hypertension. 1995 Jan; 25(1):30-6.
    View in: PubMed
    Score: 0.002
  136. Sensitization of human alpha 1- and alpha 2-adrenergic venous responses by guanadrel sulfate. Clin Pharmacol Ther. 1990 Nov; 48(5):537-43.
    View in: PubMed
    Score: 0.002
  137. Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med. 1990 Feb 15; 112(4):270-7.
    View in: PubMed
    Score: 0.002
  138. Sustained saline-induced secretion of atrial natriuretic hormone is not maintained by atrial stretch. J Clin Endocrinol Metab. 1989 Apr; 68(4):735-9.
    View in: PubMed
    Score: 0.001
  139. Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension. Hypertension. 1987 May; 9(5):459-66.
    View in: PubMed
    Score: 0.001
  140. Decreased venous distensibility and reduced renin responsiveness in hypertension. Hypertension. 1986 Jun; 8(6 Pt 2):II36-43.
    View in: PubMed
    Score: 0.001
  141. Anger and anxiety in borderline hypertension. Psychosom Med. 1986 Mar-Apr; 48(3-4):242-8.
    View in: PubMed
    Score: 0.001
  142. Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension. 1983 Mar-Apr; 5(2 Pt 2):I184-91.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.